Marshall Wace’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Other funds holding BVS
EWM
JIC
NCM
RA
Marshall Wace's BVS Position: Q2 2026 in Review
Marshall Wace sold out of Bioventus (BVS) in Q2 2026, closing a stake of 103,528 shares — an estimated $945K sold.
Marshall Wace first reported a position in BVS in Q1 2021 and held it in 15 quarters. The position peaked at $4.55M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.
- Marshall Wace reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
- Marshall Wace sold 103,528 Bioventus shares in Q2 2026, an estimated $945K.
- Marshall Wace first reported a position in Bioventus in Q1 2021 and held it in 15 quarters.
- Marshall Wace's Bioventus position peaked at $4.55M in Q3 2024.
- 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.